相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monomeric Synucleins Generate Membrane Curvature
Christopher H. Westphal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Parkinson's disease subtypes: lost in translation?
Connie Marras et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization
Shireen A. Sarraf et al.
NATURE (2013)
Motor neuron involvement in multisystem proteinopathy: Implications for ALS
Michael Benatar et al.
NEUROLOGY (2013)
Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis
Masaoki Takano et al.
NEUROSCIENCE LETTERS (2013)
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
Arthur G. Fitzmaurice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo
Evelyn S. Vincow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration
Jeriel T. R. Keeney et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry
Xiaping Zhang et al.
ANALYST (2012)
Redox Proteomics
D. Allan Butterfield et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease
Fabio Di Domenico et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes
Mia Deschepper et al.
BRAIN RESEARCH BULLETIN (2012)
Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis
Tamara Ratovitski et al.
CELL CYCLE (2012)
Mass spectrometry-based proteomics: existing capabilities and future directions
Thomas E. Angel et al.
CHEMICAL SOCIETY REVIEWS (2012)
Huntington's disease
Ainhi D. Ha et al.
CURRENT OPINION IN NEUROLOGY (2012)
SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells
Dale Chaput et al.
ELECTROPHORESIS (2012)
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia
Valentina Albertini et al.
ELECTROPHORESIS (2012)
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia
Stefan Lehnert et al.
EXPERIMENTAL NEUROLOGY (2012)
Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics
A. Cocciolo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery
Rocco Savino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Proteomic Analysis of Wild-type and Mutant Huntingtin-associated Proteins in Mouse Brains Identifies Unique Interactions and Involvement in Protein Synthesis
Brady P. Culver et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study
Andreas Wolfram Henkel et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients
Saadia Zahid et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease
Virginie Licker et al.
JOURNAL OF PROTEOMICS (2012)
Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients
Maria Zellner et al.
JOURNAL OF PROTEOMICS (2012)
Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy
Noriko Ishigami et al.
MOVEMENT DISORDERS (2012)
Update on Genetics of Parkinsonism
Shinsuke Fujioka et al.
NEURODEGENERATIVE DISEASES (2012)
The Molecular Pathology of Alzheimer's Disease
Charles R. Harrington
NEUROIMAGING CLINICS OF NORTH AMERICA (2012)
A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid
Dorien Wijte et al.
METHODS (2012)
Mass spectrometric identification of novel posttranslational modification sites in Huntingtin
Gaofeng Dong et al.
PROTEOMICS (2012)
Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach
Han-Min Chen et al.
CLINICAL BIOCHEMISTRY (2011)
Differentiation of neuronal cells from NIH/3T3 fibroblasts under defined conditions
Zhuo Wang et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2011)
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Combined with Magnetic Beads for Detecting Serum Protein Biomarkers in Parkinson's Disease
Yao-Hua Li et al.
EUROPEAN NEUROLOGY (2011)
Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study
Alexandra Dumitriu et al.
HUMAN MOLECULAR GENETICS (2011)
Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease
Eric B. Dammer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Quantitative Proteomic Approach to Prion Disease Biomarker Research: Delving into the Glycoproteome
Xin Wei et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects
Fabio Di Domenico et al.
JOURNAL OF PROTEOMICS (2011)
Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease
Jose L. Chou et al.
JOURNAL OF PROTEOMICS (2011)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Michael A. Nalls et al.
LANCET (2011)
Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome
Woong Kim et al.
MOLECULAR CELL (2011)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease
Yen-Chu Huang et al.
PLOS ONE (2011)
Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
Madhav Thambisetty et al.
PLOS ONE (2011)
Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells
Giovanni Nardo et al.
PLOS ONE (2011)
Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
Holger Jahn et al.
PLOS ONE (2011)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway
Iria Carballo-Carbajal et al.
CELLULAR SIGNALLING (2010)
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Carlo Rodolfo et al.
EXPERT REVIEW OF PROTEOMICS (2010)
Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ
Parvathi Rudrabhatla et al.
FASEB JOURNAL (2010)
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis
Tiziana Alberio et al.
FEBS JOURNAL (2010)
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2
Cindy H. Hsu et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Region-Specific Protein Abundance Changes in the Brain of MPTP-Induced Parkinson's Disease Mouse Model
Xu Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Shaking the genome: new studies reveal genetic risk for Parkinson's disease
Vincenzo Bonifati
LANCET NEUROLOGY (2010)
LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins
C. H. Hsu et al.
NEURODEGENERATIVE DISEASES (2010)
Proteome analysis of the sera from Chinese Parkinson's disease patients
Xin Zhao et al.
NEUROSCIENCE LETTERS (2010)
Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS)
Johannes Brettschneider et al.
NEUROSCIENCE LETTERS (2010)
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
Min Shi et al.
NEUROSCIENCE LETTERS (2010)
Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
Radu Constantinescu et al.
PARKINSONISM & RELATED DISORDERS (2010)
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
Walter Kolch et al.
NATURE REVIEWS CANCER (2010)
Proteomics in animal models of Alzheimer's and Parkinson's diseases
Rena A. Sowell et al.
AGEING RESEARCH REVIEWS (2009)
Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease
Irene M. Riederer et al.
BRAIN RESEARCH BULLETIN (2009)
Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach
Ashima Sinha et al.
CLINICA CHIMICA ACTA (2009)
Dissecting protein function and signaling using protein microarrays
Alejandro Wolf-Yadlin et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
G. D. Cuny
CURRENT PHARMACEUTICAL DESIGN (2009)
LRRK2 in Parkinson's disease: genetic and clinical studies from patients
Udhaya Kumari et al.
FEBS JOURNAL (2009)
Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells
Tamara Ratovitski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro
Christian Johannes Gloeckner et al.
JOURNAL OF NEUROCHEMISTRY (2009)
A Large Number of Protein Expression Changes Occur Early in Life and Precede Phenotype Onset in a Mouse Model for Huntington Disease
Claus Zabel et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Building ubiquitin chains: E2 enzymes at work
Yihong Ye et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Genetic Aspects of Alzheimer Disease
Jennifer Williamson et al.
NEUROLOGIST (2009)
Role of axonal transport in neurodegenerative diseases
Kurt J. De Vos et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
alpha-synuclein and Parkinson's disease: a proteomic view
Mauro Fasano et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
M. Alba Sorolla et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Proteomic identification of novel proteins associated with Lewy bodies
Qiangwei Xia
Frontiers in Bioscience-Landmark (2008)
Redox proteomics: basic principles and future perspectives for the detection of protein oxidation in plants
Sara Rinalducci et al.
JOURNAL OF EXPERIMENTAL BOTANY (2008)
Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease
Mark H. Chin et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform
Sheng Pan et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Quantitative proteomics of a presymptomatic A53T α-synuclein drosophila model of Parkinson disease
Zhiyin Xun et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry
Judit Villen et al.
NATURE PROTOCOLS (2008)
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Lars Bertram et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Biomarker discovery: proteome fractionation and separation in biological samples
Peter Matt et al.
PHYSIOLOGICAL GENOMICS (2008)
Genetics of Parkinson disease
Nathan Pankratz et al.
GENETICS IN MEDICINE (2007)
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Helene Plun-Favreau et al.
NATURE CELL BIOLOGY (2007)
Proteomics from the clinical perspective: many hopes and much debate
Laura Beretta
NATURE METHODS (2007)
Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease
Robert E. Burke
PHARMACOLOGY & THERAPEUTICS (2007)
Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach
Ming-Chang Chiang et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Proteomic identification of novel proteins in cortical Lewy bodies
James B. Leverenz et al.
BRAIN PATHOLOGY (2007)
Characterization of Proteins Associated with Polyglutamine Aggregates A Novel Approach Towards Isolation of Aggregates from Protein Conformation Disorders
Yan Wang et al.
PRION (2007)
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
Annette Dalrymple et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Proteomic analysis of glutathione transferases from the liver fluke parasite, Fasciola hepatica
Gustavo Chemale et al.
PROTEOMICS (2006)
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin et al.
NATURE (2006)
The roles of intracellular protein-degradation pathways in neurodegeneration
David C. Rubinsztein
NATURE (2006)
Genetics of Parkinson's disease and parkinsonism
John Hardy et al.
ANNALS OF NEUROLOGY (2006)
Genes and the environment in neurodegeneration
Fabio Coppede et al.
BIOSCIENCE REPORTS (2006)
Automated ultra-high-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples
Akira Motoyama et al.
ANALYTICAL CHEMISTRY (2006)
Synapse formation and function is modulated by the amyloid precursor protein
Christina Priller et al.
JOURNAL OF NEUROSCIENCE (2006)
Identification of potential CSF biomarkers in ALS
GM Pasinetti et al.
NEUROLOGY (2006)
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach
R Sultana et al.
NEUROBIOLOGY OF DISEASE (2006)
Proteomics-driven progress in neurodegeneration research
Michael Fountoulakis et al.
ELECTROPHORESIS (2006)
Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
Rattanavijit Vijitruth et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease
C D'Ambrosio et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods
Alfred N. Fonteh et al.
DISEASE MARKERS (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
In search of genes involved in neurodegenerative disorders
LM Pardo et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis
S Ranganathan et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Genetics of Parkinson's disease
T Gasser
CURRENT OPINION IN NEUROLOGY (2005)
A proteomic approach in the study of an animal model of Parkinson's disease
A De Iuliis et al.
CLINICA CHIMICA ACTA (2005)
Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining
T Stasyk et al.
ELECTROPHORESIS (2005)
SOD1 mutations in amyotrophic lateral sclerosis
S Battistini et al.
JOURNAL OF NEUROLOGY (2005)
Amyloid fibrils from the viewpoint of protein folding
S Ohnishi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
DJ-1 has a role in antioxidative stress to prevent cell death
T Taira et al.
EMBO REPORTS (2004)
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents
PL Ross et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms
V Bonifati et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Protein aggregation and neurodegenerative disease
CA Ross et al.
NATURE MEDICINE (2004)
Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis
K Fukada et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
The importance of neuritic plaques and tangles to the development and evolution of AD
P Tiraboschi et al.
NEUROLOGY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Ubiquitination of α-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function
GK Tofaris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism
V Bonifati et al.
NEUROLOGICAL SCIENCES (2003)
The prevalence and causes of dementia in people under the age of 65 years
RJ Harvey et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
A proteomics approach to understanding protein ubiquitination
JM Peng et al.
NATURE BIOTECHNOLOGY (2003)
Global quantitative phosphoprotein analysis using multiplexed proteomics technology
TH Steinberg et al.
PROTEOMICS (2003)
Ubiquitination of α-synuclein is not required for formation of pathological inclusions in α-synucleinopathies
DM Sampathu et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Redox proteomics: Identification of oxidatively, modified proteins
P Ghezzi et al.
PROTEOMICS (2003)
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
PR Turner et al.
PROGRESS IN NEUROBIOLOGY (2003)
Tandem mass tags:: A novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS
A Thompson et al.
ANALYTICAL CHEMISTRY (2003)
Mass spectrometry-based proteomics
R Aebersold et al.
NATURE (2003)
The spectrum of lower motor neuron syndromes
RM Van den Berg-Vos et al.
JOURNAL OF NEUROLOGY (2003)
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases
M Hashimoto et al.
NEUROMOLECULAR MEDICINE (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Genetic and environmental factors in cancer and neurodegenerative diseases
L Migliore et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2002)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1β and amyloid β42 peptide is potentiated by hypoxia in primary human neural cells
NG Bazan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Akt1 regulates a JNK scaffold during excitotoxic apoptosis
AH Kim et al.
NEURON (2002)
Biomedicine - Toxic proteins in neurodegenerative disease
JP Taylor et al.
SCIENCE (2002)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification
HJ Issaq et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Applied proteomics - Mitochondrial proteins and effect on function
MF Lopez et al.
CIRCULATION RESEARCH (2002)
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
F Liu et al.
FEBS LETTERS (2002)
Genotype and phenotype in Alzheimer's disease
C Holmes
BRITISH JOURNAL OF PSYCHIATRY (2002)
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
M Funayama et al.
ANNALS OF NEUROLOGY (2002)
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36
EM Valente et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Synucleinopathies - Clinical and pathological implications
JE Galvin et al.
ARCHIVES OF NEUROLOGY (2001)
Prion diseases of humans and animals: Their causes and molecular basis
J Collinge
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease
J Sáez-Valero et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Oxidative stress and genetics in the pathogenesis of Parkinson's disease
Y Zhang et al.
NEUROBIOLOGY OF DISEASE (2000)
分享论文
